For over a quarter of a century now, Pharmaprojects' R&D Annual Review has been a useful opportunity to pause and reflect on the evolution of the pharma R&D universe. 2014 was a stellar year for new drug approvals and the overall pipeline continues to grow, showing no signs of slowing or reversing. With companies facing commercial and pricing pressures like never before, can our R&D universe expand forever or could we soon see the pharmaceutical industry gradually running out energy, or indeed, funds? In a year that saw an unprecedented number of new drugs reaching the market, is productivity at this rate sustainable?+ More details
The UK Parliament recently authorised a radical medical procedure that involves the reproductive cells of one man and two women. Miracle of bio-technology or a disaster waiting to happen? Viewer feedback welcome — Email firstname.lastname@example.org — Facebook Record.Mag — Twitter @RecordInFocus+ More details
Looking for a list of the best NASDAQ Penny stocks in the Biotech industry… here it is!+ More details
MG - Adventures "with the Skyman" VELOCITIY besser kann man den film nit bezeichnen zumal die ganze nacht der wind pfiff dass i bold wahnsinnig wordn war :-) es lebm isch zu kurz um dahoam zu sitzn und NOSENBOHRN !! take off today 5.15 a.m. Kesselspitz nord leichte turbulenzen in kammnähe :-) good morning Skyman+ More details
A short demo video of the proposed public artwork for the Jennie Smoly Caruthers Biotechnology Building at the University of Colorado Boulder. This video shows an example of "swarming" motility.+ More details
A short demo video of the proposed public artwork for the Jennie Smoly Caruthers Biotechnology Building at the University of Colorado Boulder. This video shows an example of "gliding" motility.+ More details
A panel discussion on the future of GM at the 2015 Cereals Event. This event was a collaboration between The Oxford Farming Conference and The Cereals Event. The panelists were: Mark Buckingham representing EuropaBio; Paul Temple, a farmer; Prof Johnathan Napier from Rothamsted and Jack Bobo, Biotechnology representative from USDA.+ More details
MG-Adventures "with the Skyman" des wor no a aktion wo schnee wor, mit Thomas Ribis, es war sturm, es war kalt, wir mussten uns in einer schneewächtn vor dem wind schützn und es wor a wohnsinn so lässig wenn die einwualn kunsch... nit olm jammern nit olm über ondere wos besser wissn, nit olm ols negativ segn... i gea olm wieder aussi und danoch bin i ondersch eingstellt... toats wos wollts mia taugts :-) :-)...habe die ehre Skyman+ More details
Erytech is a French oncology company with a red blood cell encapsulation technology. Lead product Graspa has successfully completed a Phase III acute lymphoblastic leukaemia trial and a Phase IIb in acute myeloid leukaemia is ongoing, in addition to a Phase II in pancreatic cancer. In this interview CEO Gil Beyen explains how Graspa works, its benefits and its other potential applications. He also sets out the company’s plans for the money raised in October 2014 and what investors should look out for in the coming months.+ More details
What are Tags?
Tags are keywords that describe videos. For example, a video of your Hawaiian vacation might be tagged with "Hawaii," "beach," "surfing," and "sunburn."